Product Description: 2,8-Dihydroxyadenine, an endogenous metabolite, can cause the formation of urinary crystals and kidney stones. 2,8-Dihydroxyadenine can be used to diagnose adenine phosphoribosyltransferase (APRT) deficiency[1][2].
Applications: Metabolism-protein/nucleotide metabolism
Formula: C5H5N5O2
References: [1]Ceballos-Picot I, et, al. 2,8-Dihydroxyadenine urolithiasis: a not so rare inborn error of purine metabolism. Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):241-52./[2]Sreejith P, et, al. 2, 8 Dihydroxyadenine urolithiasis: A case report and review of literature. Indian J Nephrol. 2009 Jan;19(1):34-6.
CAS Number: 30377-37-8
Molecular Weight: 167.13
Compound Purity: 98.0
Research Area: Metabolic Disease
Solubility: H2O : 2.2 mg/mL (ultrasonic;warming)
Target: Endogenous Metabolite